On Monday, July 6, 2026, Bryan Johnson — the American entrepreneur known for his longevity experiments — announced that he has been diagnosed with a rare autoimmune disorder that attacks the stomach lining. The news was shared through his Instagram account and quickly gained attention, given Johnson’s reputation for investing millions annually in anti‑aging research and advanced medical treatments.
Johnson, who has often spoken about his ambition to live to 160 years old, described the illness with the striking phrase: “My stomach is eating itself.” His disclosure sparked concern among followers and reignited discussions about the unpredictable nature of autoimmune diseases.
Medical specialists note that such conditions are challenging to identify because symptoms often emerge slowly and resemble other digestive problems. If untreated, the disease can impair nutrient absorption, leading to deficiencies, anemia, and other long‑term complications.
Despite Johnson’s strict nutrition plans, cutting‑edge monitoring, and experimental therapies, his diagnosis underscores that even those with access to the most advanced health technologies remain vulnerable to complex medical challenges. Experts stress that early detection and proper treatment are critical for managing autoimmune disorders, with routine medical evaluations helping to prevent severe outcomes.
Johnson’s revelation has stirred fresh debate within the global health and longevity community. While he continues to pursue his mission of extending human life, his experience serves as a reminder that scientific progress can improve health tracking but cannot fully eliminate the risk of serious disease.